申请人:Shigeta Yukihiro
公开号:US20120209005A1
公开(公告)日:2012-08-16
Fused heterocyclic compounds useful for prevention, treatment or improvement of diseases against which activation of the thrombopoietin receptor is effective are provided.
A compound represented by the formula (I) (wherein R
1
is an aryl group fused to a saturated ring or the like, A, B, L
1
, R
2
, L
2
, L
3
, Y, L
4
, R
3
and X are defined in the description), a tautomer, prodrug or a pharmaceutically acceptable salt of the compound or a solvate thereof.
提供了对激活血小板生成素受体有效的疾病的预防、治疗或改善有用的融合杂环化合物。代表式(I)的化合物(其中R1是与饱和环或类似物融合的芳基,A、B、L1、R2、L2、L3、Y、L4、R3和X在描述中有定义),该化合物的互变异构体、前药或药用可接受的盐或其溶剂化物。